Recon: FDA approves Bristol Myers Opdivo for early-stage lung cancer; Pfizer recalls two blood pressure drugs in Canada over carcinogen concerns
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy